Cytek Biosciences, Inc. Profile Avatar - Palmy Investing

Cytek Biosciences, Inc.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytomete…

Medical - Devices
US, Fremont [HQ]

Risk Factors

By Management
10-K
  1. Our amended and restated certificate of incorporation and amended and restated bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.

  2. Obtaining and maintaining our intellectual property, including patent, protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by government agencies, and our intellectual property, including patent, protection could be reduced or eliminated for non-compliance with these requirements.

  3. If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our operating results could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock.

Get PRO Today.

Read 22 more risk factors of Cytek Biosciences, Inc.

End of CTKB's Analysis
CIK: 1831915 CUSIP: 23285D109 ISIN: US23285D1090 LEI: - UEI: -
Secondary Listings
CTKB has no secondary listings inside our databases.